Bleakley Financial Group
RDY icon

Bleakley Financial Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Bleakley Financial Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,998
Closed -$239K – 785
2025
Q4 		$239K Buy
16,998
+1,813
+12% +$25.4K ﹤0.01% 670
2025
Q3 		$212K Buy
15,185
+319
+2% +$4.59K ﹤0.01% 583
2025
Q2 		$223K Buy
+14,866
New +$212K 0.01% 563

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bleakley Financial Group's RDY Position: Q1 2026 in Review

Bleakley Financial Group sold out of Dr. Reddy's Laboratories (RDY) in Q1 2026, closing a stake of 16,998 shares — an estimated $239K sold.

Bleakley Financial Group first reported a position in RDY in Q2 2025 and held it in 3 quarters. The position peaked at $239K in Q4 2025. 249 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Bleakley Financial Group reported no remaining Dr. Reddy's Laboratories position as of Q1 2026 after selling out during the quarter.
  • Bleakley Financial Group sold 16,998 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $239K.
  • Bleakley Financial Group first reported a position in Dr. Reddy's Laboratories in Q2 2025 and held it in 3 quarters.
  • Bleakley Financial Group's Dr. Reddy's Laboratories position peaked at $239K in Q4 2025.
  • 249 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Bleakley Financial Group's 13F filing for Q1 2026, filed 4 May 2026.